Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00147329
What this trial is testing

Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Merrimack Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT02387801
What this trial is testing

The Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04862286
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

Who this might be right for
Psoriasis
AbbVie 132
Large-scale testing (Phase 3)Study completedNCT05645627
What this trial is testing

Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 500
Testing effectiveness (Phase 2)Study completedNCT04566666
What this trial is testing

To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Sun Pharmaceutical Industries Limited 263
Not applicableLooking for participantsNCT06030076
What this trial is testing

Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 50
Post-approval studies (Phase 4)Study completedNCT04263610
What this trial is testing

Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 190
Large-scale testing (Phase 3)Study completedNCT03818035
What this trial is testing

Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag International NV 880
Post-approval studies (Phase 4)Not Yet RecruitingNCT06779097
What this trial is testing

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 1,564
Large-scale testing (Phase 3)Study completedNCT06039189
What this trial is testing

Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

Who this might be right for
Moderate Plaque Psoriasis
Janssen Research & Development, LLC 338
Post-approval studies (Phase 4)Study completedNCT00988637
What this trial is testing

Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Galderma R&D 138
Not applicableLooking for participantsNCT06258668
What this trial is testing

Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Bristol-Myers Squibb 505
Large-scale testing (Phase 3)Study completedNCT04673786
What this trial is testing

Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Celltrion 509
Large-scale testing (Phase 3)Study completedNCT02660580
What this trial is testing

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Type PsoriasisModerate to Severe Plaque Psoriasis
Fresenius Kabi SwissBioSim GmbH 443
Post-approval studies (Phase 4)Looking for participantsNCT06857942
What this trial is testing

Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Who this might be right for
PsoriasisOverweight or Obesity
Eli Lilly and Company 200
Testing effectiveness (Phase 2)Ended earlyNCT03179605
What this trial is testing

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Who this might be right for
Psoriasis
Primus Pharmaceuticals 22
Large-scale testing (Phase 3)Study completedNCT02634801
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 162
Not applicableLooking for participantsNCT06696417
What this trial is testing

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
First Hospital of China Medical University 1,516
Post-approval studies (Phase 4)Ended earlyNCT00972543
What this trial is testing

Raptiva in Palm and Sole Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 6
Post-approval studies (Phase 4)Ended earlyNCT00739882
What this trial is testing

TRUST Study: Raptiva ® in Hand & Foot Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 76
Next Page